These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31778882)

  • 21. Immunostimulatory nucleic acid nanoparticles (NANPs) augment protective osteoblast and osteoclast type I interferon responses to Staphylococcus aureus.
    Mills EL; Avila YI; Beasock D; Radwan Y; Suptela SR; Marriott I; Afonin KA; Johnson MB
    Nanomedicine; 2024 Jun; 60():102762. PubMed ID: 38866196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulating Immune Response with Nucleic Acid Nanoparticles.
    Durbin JK; Miller DK; Niekamp J; Khisamutdinov EF
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticles.
    Newton HS; Radwan Y; Xu J; Clogston JD; Dobrovolskaia MA; Afonin KA
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37298960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Application of Light-Assisted Drying to the Thermal Stabilization of Nucleic Acid Nanoparticles.
    Anh Lam P; Furr DP; Tran A; McKeough RQ; Beasock D; Chandler M; Afonin KA; Trammell SR
    Biopreserv Biobank; 2022 Oct; 20(5):451-460. PubMed ID: 36067075
    [No Abstract]   [Full Text] [Related]  

  • 25. Simultaneous silencing of lysophosphatidylcholine acyltransferases 1-4 by nucleic acid nanoparticles (NANPs) improves radiation response of melanoma cells.
    Saito RF; Rangel MC; Halman JR; Chandler M; de Sousa Andrade LN; Odete-Bustos S; Furuya TK; Carrasco AGM; Chaves-Filho AB; Yoshinaga MY; Miyamoto S; Afonin KA; Chammas R
    Nanomedicine; 2021 Aug; 36():102418. PubMed ID: 34171470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
    Panigaj M; Johnson MB; Ke W; McMillan J; Goncharova EA; Chandler M; Afonin KA
    ACS Nano; 2019 Nov; 13(11):12301-12321. PubMed ID: 31664817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticles.
    Dobrovolskaia MA; Afonin KA
    Nat Protoc; 2020 Nov; 15(11):3678-3698. PubMed ID: 33097923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Nonmodified Wireframe DNA Origami for Acute Toxicity and Biodistribution in Mice.
    Wamhoff EC; Knappe GA; Burds AA; Du RR; Neun BW; Difilippantonio S; Sanders C; Edmondson EF; Matta JL; Dobrovolskaia MA; Bathe M
    ACS Appl Bio Mater; 2023 May; 6(5):1960-1969. PubMed ID: 37040258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immune responses to RNA: sensing and signaling.
    Luan X; Wang L; Song G; Zhou W
    Front Immunol; 2024; 15():1287940. PubMed ID: 38343534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation.
    Afonin KA; Dobrovolskaia MA; Ke W; Grodzinski P; Bathe M
    Adv Drug Deliv Rev; 2022 Feb; 181():114081. PubMed ID: 34915069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immune recognition of nucleic acids: beyond toll-like receptors.
    Ishii KJ; Akira S
    Int J Cancer; 2005 Nov; 117(4):517-23. PubMed ID: 16080197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding Structural Space for Immunomodulatory Nucleic Acid Nanoparticles (Nanps) via Spatial Arrangement of Their Therapeutic Moieties.
    Chandler M; Rolband L; Johnson MB; Shi D; Avila YI; Cedrone E; Beasock D; Danai L; Stassenko E; Krueger JK; Jiang J; Lee JS; Dobrovolskaia MA; Afonin KA
    Adv Funct Mater; 2022 Oct; 32(43):. PubMed ID: 37008199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Characterization of Nucleic Acid Nanoparticles Using SAXS and SAXS-Driven MD.
    Byrnes J; Chopra K; Rolband LA; Danai L; Chodankar S; Yang L; Afonin KA
    Methods Mol Biol; 2023; 2709():65-94. PubMed ID: 37572273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial: Delivering nucleic acids to immune and non-immune cells.
    Afonin KA; Re F; Boraschi D
    Front Immunol; 2023; 14():1237506. PubMed ID: 37614239
    [No Abstract]   [Full Text] [Related]  

  • 35. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
    Iurescia S; Fioretti D; Rinaldi M
    Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toehold-Mediated Shape Transition of Nucleic Acid Nanoparticles.
    Hartung J; McCann N; Doe E; Hayth H; Benkato K; Johnson MB; Viard M; Afonin KA; Khisamutdinov EF
    ACS Appl Mater Interfaces; 2023 May; 15(21):25300-25312. PubMed ID: 37204867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Light-Assisted Drying for the Thermal Stabilization of Nucleic Acid Nanoparticles and Other Biologics.
    Trammell SR
    Methods Mol Biol; 2023; 2709():117-130. PubMed ID: 37572276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology.
    Afonin KA; Dobrovolskaia MA; Church G; Bathe M
    ACS Nano; 2020 Aug; 14(8):9221-9227. PubMed ID: 32706238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleic Acid Immunity.
    Hartmann G
    Adv Immunol; 2017; 133():121-169. PubMed ID: 28215278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies.
    Dobrovolskaia MA
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31861154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.